Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Bortezomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 89 Neoplasms, Plasma Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 6 Immunoglobulin Light-chain Amyloidosis 6 Recurrence 5 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Paraproteinemias 3 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Renal Insufficiency 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Amyloidosis 2 beta-Thalassemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Sarcoma, Myeloid 1 Plasmacytoma 1 Peripheral Nervous System Diseases 1 Neoplasm, Residual 1

Interventions

Rituximab 41 Cyclophosphamide 31 Lenalidomide 24 fludarabine 19 zanubrutinib 12 venetoclax 11 obinutuzumab 11 fludarabine phosphate 9 Bendamustine Hydrochloride 9 orelabrutinib 8 ibrutinib 8 Vincristine 8 Magnetic Resonance Spectroscopy 8 pirtobrutinib 7 Whole-Body Irradiation 7 Prednisone 7 Specimen Handling 6 Doxorubicin 6 CT-P10 6 Mycophenolic Acid 5 Etoposide 5 Biopsy 5 pembrolizumab 4 Nivolumab 4 Melphalan 4 tafasitamab 3 Sirolimus 3 Cyclosporine 3 parsaclisib 2 copanlisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡